[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:splenic-marginal-zone-lymphoma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":42,"states":43},"Splenic Marginal Zone Lymphoma",5,4,[8,16,23,29,35],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06796998","Epcoritamab in Patients With Newly Diagnosed Marginal Zone Lymphoma (MZL)",[12],"Phase 2","RECRUITING","2026-08-26T02:17:40.683658Z","2026-05-05T02:43:28.497607Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT05544019","Study of SGR-1505 in Mature B-Cell Neoplasms",[20],"Phase 1","2026-08-26T02:15:49.658025Z","2026-05-05T02:43:28.973931Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT04223765","Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed\u002FRefractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia\u002FSmall Lymphocytic Lymphoma.",[20],"2026-08-26T02:19:12.219640Z","2026-05-05T02:43:28.733566Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT06712459","Integrated Molecular and Clinical Profiling of Transformed Splenic Marginal Zone Lymphoma",[],"2026-08-26T02:16:49.565137Z","2026-05-13T02:55:06.564190Z",{"nct_id":36,"title":37,"phases":38,"status":39,"updated_at":40,"content_modified":41},"NCT07583810","Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma",[12],"NOT_YET_RECRUITING","2026-08-26T02:16:32.589113Z","2026-05-29T15:36:40.196726Z",[],[]]